Healio Minute

In this edition, European commission approves Beovu for DME, choroidal vascularity index linked with geographic atrophy progression, intravitreal gene therapy effective, safe in Leber hereditary optic neuropathy, and more. Read the full coverage here: Susvimo noninferior to monthly ranibizumab with similar efficacy European Commission approves Beovu for DME Intravitreal gene therapy effective, saf...

In this week's edition, the FDA approval of an oral anticonvulsant; plus news you may have missed from the AAN and ACTRIMS meetings. Read the full coverage here: FDA approves oral anticonvulsant New drug improved tic severity in children with Tourette syndrome Vitamin D levels not associated with adverse outcomes in European MS patients Zolpidem may be effective for prolonged disorders of consciou...

In this edition, digital imaging and AI advance investigation of systemic disease through the retina; handheld retinal imaging devices may have utility in screening; Xipere launches in the US; and more. Read the full coverage here: Digital imaging, AI advance investigation of systemic disease through the retina No additional visual benefit seen with nesvacumab-aflibercept combination in DME Soft d...

In this edition, a phase 3 trial of a regimen for small cell lung cancer misses its co-primary endpoint; obesity and pulmonary function may identify the need for home oxygen after lung cancer surgery; a study finds that lung cancer screening is less common among those most likely to benefit from it; and more. Read the full coverage here: Phase 3 trial of regimen for small cell lung cancer misses c...

This week, a speaker predicts the AMD epidemic will continue to challenge ophthalmologists; pegcetacoplan results in 18-month reduction in GA lesion growth; interim trial results show efficacy of photo-bio-modulation in dry AMD; and more. Read the full coverage here: AMD epidemic will continue to challenge ophthalmologists Reduction in GA lesion growth continues at 18 months with pegcetacoplan Int...

In this week's addition, the FDA approval of a transdermal patch to treat Alzheimer's-related dementia; the link between daily napping among older adults and an increased risk for Alzheimer's disease; an oral treatment for Parkinson's demonstrated positive phase 2 results; and more. Read the full coverage here: FDA approves transdermal patch to treat Alzheimer's-related dementia Daily napping amon...